Skip to main content
SpringerLink
Log in

Darunavir in the Treatment of HIV-1 Infection

A Viewpoint by Renslow Sherer

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Whitman S, Murphy J, Cohen M, et al. Marked declines in HIV-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users from 1995–1997. Arch Int Med 2000; 160: 365–69

    Article  CAS  Google Scholar 

  2. Lampe F, Gatell J, Staszewski S, et al. Trends over time in initial virologic failure of first HAART, 1996–2002: a joint cohort analysis of 4,143 subjects [abstract no. 593]. 12th Conference on Retroviruses and Opportunistic Infections; 2005 Feb 22–25; Boston (MA)

  3. Cohen M, Green L, Pulvirenti J, et al. Trends in mortality in persons with HIV, Chicago, 1996–2000 [abstract no. 338]. XIXth World AIDS Conference; 2002 Jul 7–12; Barcelona

  4. Fris-Mueller N, Reiss P, El-Sadr W, et al. Exposure to PI and NNRTI and risk of myocardial infarction: results from the D:A:D Study [abstract no. 144]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5–8; Denver (CO)

  5. Bennett D, McCormick L, Kline R, et al. US Surveillance of HIV drug resistance at diagnosis using HIV diagnostic sera [abstract no. 674]. 12th Conference on Retroviruses and Opportunistic Infections; 2005 Feb 22–25; Boston (MA)

  6. Viani R, Peralta L, Aldrovandi G, et al. Prevalence of primary HIV drug resistance among recently infected adolescents: a multi-center adolescent trials network study: ATN029 [abstract no. 21]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5–8; Denver (CO)

  7. Saag M. New agents and treatment paradigms: navigating through the drug development mine field [abstract 118]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5–8; Denver (CO)

Download references

Author information

Authors and Affiliations

  1. International AIDS Training Center, Department of Medicine, University of Chicago, Chicago, Illinois, USA

    Renslow Sherer

Authors
  1. Renslow Sherer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherer, R. Darunavir in the Treatment of HIV-1 Infection. Drugs 67, 2802 (2007). https://doi.org/10.2165/00003495-200767180-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200767180-00011

Search

Navigation